|
Nature Briefing article
|
5
|
Resverlogix Corp.
|
Feb 18, 2022 10:16AM
|
|
Re: Debenture questions.
|
3
|
Resverlogix Corp.
|
Feb 17, 2022 12:57PM
|
|
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
10
|
Resverlogix Corp.
|
Feb 17, 2022 12:31PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
3
|
Zenith Epigenetics
|
Feb 15, 2022 11:37AM
|
|
Corporate Year ends
|
3
|
Resverlogix Corp.
|
Feb 10, 2022 07:01PM
|
|
Re: The costs of Long Covid
|
6
|
Resverlogix Corp.
|
Feb 08, 2022 01:51PM
|
|
Re: CBC Radio News Interview with Dr. Sweeney
|
10
|
Resverlogix Corp.
|
Feb 07, 2022 01:10PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
6
|
Zenith Epigenetics
|
Feb 07, 2022 12:27PM
|
|
Re: New video quietly released
|
8
|
Resverlogix Corp.
|
Jan 29, 2022 01:15PM
|
|
Re: Round one
|
1
|
Resverlogix Corp.
|
Jan 28, 2022 06:19AM
|
|
Re: Round one
|
7
|
Resverlogix Corp.
|
Jan 27, 2022 02:26PM
|
|
Re: Round one
|
6
|
Resverlogix Corp.
|
Jan 27, 2022 01:17PM
|
|
Re: Listen to Dr. Michael Sweeney.
|
5
|
Resverlogix Corp.
|
Jan 25, 2022 12:23PM
|
|
Re: INTERESTING TAKE FROM STAT
|
4
|
Resverlogix Corp.
|
Jan 23, 2022 01:29PM
|
|
Re: Good news thoughts
|
5
|
Resverlogix Corp.
|
Jan 18, 2022 12:47PM
|
|
Good news thoughts
|
7
|
Resverlogix Corp.
|
Jan 18, 2022 10:53AM
|
|
Trial started
|
7
|
Resverlogix Corp.
|
Jan 18, 2022 07:49AM
|
|
Sleep
|
3
|
Zenith Epigenetics
|
Jan 13, 2022 11:08AM
|
|
Re: from Sarah yesterday afternoon...
|
7
|
Resverlogix Corp.
|
Jan 12, 2022 11:18AM
|
|
Re: Another reason
|
6
|
Resverlogix Corp.
|
Jan 10, 2022 05:19PM
|
